Skip to main content
. 2020 Apr 14;2(4):100116. doi: 10.1016/j.jhepr.2020.100116

Table 3.

Discriminant function of laboratory tests for benign vs. malignant hepato-pancreato-biliary disease in 213 consecutive patients presented at a specialized multidisciplinary outpatient clinic.

Benign disease
(n = 35)
Malignant disease
(n = 178)
p value
IgG4/IgG RNA ratio, % 4.0 (2.1–6.9) 3.9 (2.0–8.2) 0.6
IgG4, g/L 0.4 (0.3–1.1) 0.5 (0.2–0.9) 0.6
CA 19.9, kU/L 16.5 (7–50) 201 (33–1,646) <0.01

Results are presented as medians (IQR); Wilcoxon-Mann-Whitney test.